| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/30/2011 | EP2302062A1 Identification of E2F target genes and uses thereof |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2302058A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 03/30/2011 | EP2302048A1 Variants with altered properties |
| 03/30/2011 | EP2302041A1 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 03/30/2011 | EP2302033A2 Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti |
| 03/30/2011 | EP2301972A1 Method to prepare immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 03/30/2011 | EP2301969A1 IL-31 monoclonal antibodies and methods of use |
| 03/30/2011 | EP2301968A2 Humanized monoclonal antibody HPAM4 |
| 03/30/2011 | EP2301964A1 High affinity HIV T cell receptors |
| 03/30/2011 | EP2301963A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 03/30/2011 | EP2301962A2 Invention affecting GLP-1 and Exendin |
| 03/30/2011 | EP2301961A1 Sclerostin epitopes |
| 03/30/2011 | EP2301960A2 Polymer conjugates of mutated neublastin |
| 03/30/2011 | EP2301959A2 Motif-grafted hybrid polypeptides and uses thereof |
| 03/30/2011 | EP2301958A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/30/2011 | EP2301957A2 Altered fibronectin-binding protein of staphylococcus aureus |
| 03/30/2011 | EP2301956A1 Methods for prognosticating progression or long term non-progression of a HIV infection or HIV-associated disorders in a patient |
| 03/30/2011 | EP2301955A2 Varicella Zoster virus vaccine |
| 03/30/2011 | EP2301954A2 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/30/2011 | EP2301953A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 03/30/2011 | EP2301948A1 Promoters for regulation of gene expression in plant roots |
| 03/30/2011 | EP2301947A2 Secreted proteins and uses thereof |
| 03/30/2011 | EP2301587A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 03/30/2011 | EP2301586A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 03/30/2011 | EP2301585A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 03/30/2011 | EP2301584A1 Methods and compositions for treatment of interferon-resistant tumors |
| 03/30/2011 | EP2301583A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301576A1 Therapeutic use of Anti-CS1 Antibodies |
| 03/30/2011 | EP2301574A1 Virulent systemic feline calicivirus |
| 03/30/2011 | EP2301568A1 Antibody against IRTA2 for the treatment of tumour of hematopoietic origin |
| 03/30/2011 | EP2301564A1 Compositions and methods for promoting neuronal outgrowth |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2301560A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue |
| 03/30/2011 | EP2301559A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 03/30/2011 | EP2300614A2 Methods and compositions for treatment of mitochondrial disorders |
| 03/30/2011 | EP2300610A1 Novel bmp-12-related proteins and methods of their manufacture |
| 03/30/2011 | EP2300609A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
| 03/30/2011 | EP2300597A1 Modified pichia strain |
| 03/30/2011 | EP2300497A1 A process of purifying coagulation factor viii |
| 03/30/2011 | EP2300496A1 Methods of treating atherosclerosis |
| 03/30/2011 | EP2300495A1 Solutions for tissue engineering and methods of use |
| 03/30/2011 | EP2300494A1 Anti-amyloid immunogenic compositions, methods and uses |
| 03/30/2011 | EP2300493A2 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300051A1 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
| 03/30/2011 | EP2300048A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
| 03/30/2011 | EP2300044A1 Methods and compositions for the management of pain using omega-conotoxins |
| 03/30/2011 | EP2300038A2 Improved peptide mediators of cholesterol efflux |
| 03/30/2011 | EP2300036A1 Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 03/30/2011 | EP2300035A2 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 03/30/2011 | EP2185588B1 Synthetic pulmonary surfactant peptides |
| 03/30/2011 | EP2167526B1 Purification of factor viii using a mixed-mode or multimodal resin |
| 03/30/2011 | EP2121736B1 New anti-malaria vaccine compositions and uses thereof |
| 03/30/2011 | EP1817338B1 Production of a von willenbrand factor preparation having a great specific activity |
| 03/30/2011 | EP1812459B1 Method for the mass production of multimeric mannose binding lectin |
| 03/30/2011 | EP1799814B1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 03/30/2011 | EP1737965B1 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants |
| 03/30/2011 | EP1577390B9 Human cancer-related genes, the products encoded thereby and applications thereof |
| 03/30/2011 | EP1572233B1 Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/30/2011 | EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | EP1394261B1 Antigens for immunisation |
| 03/30/2011 | EP1337242B1 Gene delivery formulations for treatment of ischemic conditions |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | CN1956995B Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 03/30/2011 | CN1863918B Packaging cells for recombinant adenovirus |
| 03/30/2011 | CN101998994A Zea mays aba signaling genes and methods of use |
| 03/30/2011 | CN101998992A Methods involving MS4A12 and agents targeting MS4A12 for therapy, diagnosis and testing |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998987A Commensal bacteria as signal mediators within a mammalian host |
| 03/30/2011 | CN101998965A Immunosuppressive polypeptides and nucleic acid |
| 03/30/2011 | CN101995467A Malachite green collaurum detection card and production and application methods thereof |
| 03/30/2011 | CN101995463A Composition for detecting rheumatoid arthritis immune antibody by dot immuno-gold filtration assay |
| 03/30/2011 | CN101995461A Sulfamethazine colloidal gold test card, production and using method thereof |
| 03/30/2011 | CN101993489A Reversible hirudin |
| 03/30/2011 | CN101993488A Ractopamine immunogen, coating antigen and use thereof in colloid-gold test paper |
| 03/30/2011 | CN101993487A Immunogen and coatinggen of chloramphenicol and application thereof in collaurum test paper |
| 03/30/2011 | CN101993486A Clenbuterol immunogen, coatingen and application thereof in colloidal gold test paper |
| 03/30/2011 | CN101993485A Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof |
| 03/30/2011 | CN101993484A Stress tolerance associated protein and coded gene and application thereof |
| 03/30/2011 | CN101993483A Protein related to plant stress tolerance, coding gene and application thereof |
| 03/30/2011 | CN101993482A Protein associated with long grain foliaceous of paddy rice and coding gene and application thereof |
| 03/30/2011 | CN101993481A Plant stress resistance related protein as well as coding gene and application thereof |
| 03/30/2011 | CN101993480A Broccoli leaf protein and preparation method thereof |
| 03/30/2011 | CN101993479A Plant stress tolerance related transcription factor TaWRKY1 as well as coding gene and application thereof |
| 03/30/2011 | CN101993478A Multi-epitope recombinant protein of epstein-barr (EB) virus latent membrane protein 2 and application thereof |
| 03/30/2011 | CN101402683B Synthesis of melamine artificial antigen |
| 03/30/2011 | CN101381731B Method for obtaining 4 type hepatitis e virus recombinant polypeptides |
| 03/30/2011 | CN101294162B P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 03/30/2011 | CN101158680B Synthetic method of carbostyrile kind antibiotic multi cluster antigen |
| 03/30/2011 | CN101085811B SARS coronavirus pharmaceutical target and application thereof |
| 03/30/2011 | CN101014617B Il-1 antagonist formulations |
| 03/29/2011 | US7915486 Plastidic phosphoglucomutase genes |
| 03/29/2011 | US7915485 Nodulation factor binding element for use in developing nitrogen-fixing root nodules in plants |
| 03/29/2011 | US7915484 Transgenic freeze and drought resistant plants; crops with enhanced resistance to enviromental stresses; plant transformed by a Protein Kinase Stress-Related Protein (PKSRP) coding nucleic acid |